Insilico utilized AlphaFold-predicted protein structures to generate a series of hinge cores (IMAGE)
Caption
Following molecular docking, synthesis, and biological evaluation, a hit molecule targeting SIK2 was obtained with a novel scaffold. Further exploration led to the discovery of a compound with superior potency against SIK2 compared to reported inhibitors.
Credit
Insilico Medicine
Usage Restrictions
none
License
Original content